Skip navigation

Achieve Excellence in Management of GTN Processes, Accounting, Estimates and Controls

June 14, 2017
  • Philadelphia, PA

Jenniffer Collins
CFO
Teligent

Patrick Coyle
Executive Director Finance,
Immunology and Dermatology Franchise – US
Novartis

Luke Greenwalt
Principal
Amundsen Consulting, a division of QuintilesIMS

Murray Kay
Former Senior Vice President & CFO, Solvay Pharmaceuticals;
Former Commercial Controller, AbbVie & Abbott Laboratories

Mike Makovec, CPA
Audit Senior Manager
Deloitte & Touche LLP

Jeffrey Miller
Director of Finance and Contract Administration
Impax Laboratories

Karim Munir
Director, Corporate Financial Reporting and Global Consolidation
Bristol-Myers Squibb

Nathan Newell
Senior Manager
Deloitte & Touche LLP

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Jenniffer Collins
CFO
Teligent

Patrick Coyle
Executive Director Finance,
Immunology and Dermatology Franchise – US
Novartis

Luke Greenwalt
Principal
Amundsen Consulting, a division of QuintilesIMS

Murray Kay
Former Senior Vice President & CFO, Solvay Pharmaceuticals;
Former Commercial Controller, AbbVie & Abbott Laboratories

Mike Makovec, CPA
Audit Senior Manager
Deloitte & Touche LLP

Jeffrey Miller
Director of Finance and Contract Administration
Impax Laboratories

Karim Munir
Director, Corporate Financial Reporting and Global Consolidation
Bristol-Myers Squibb

Nathan Newell
Senior Manager
Deloitte & Touche LLP

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., a Revenue Analytics Company

Walt Worsham
Senior Manager
Deloitte & Touche LLP